SCANDINAV. REAL HEART AB Aktie

Loading quotes...

Forecast

There is no analyst data available for this company.

News Go to news feed

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics

In 2022, SCANDINAV. REAL HEART AB Aktie has already paid €0.0434 in dividends. The last payout was in June 2022.

Financials

In the last quarter, SCANDINAV. REAL HEART AB Aktie had revenue of €0 and net profit of -€783.45k

(EUR)	June 2025	YoY
Revenue	0	-
Gross profit	603.56k	-
Net profit	-783.45k	-
EBITDA	-320.88k	-

Fundamentals

Metric	Value
Market capitalization	€13.05m
Number of shares	8.5m
52-week high/low	€2.15 - €1.17
Dividends	No
Beta	1.18
P/E ratio	-2.39
PEG ratio	-0.25
P/B ratio	1.36
P/S ratio	0.00

Company profile

Scandinavian Real Heart AB (Publ) designs and develops an artificial heart. It engages in developing Realheart TAH to treat advanced stage heart failure. It also develops RealVAD, PulsePump, and Sternal Prosthesis products. The company was incorporated in 2007 and is based in Västerås, Sweden.